Skip to content
sellWeak cluster of 510b5-1 plan

Soleil Boughton sold $463k of HIMS

Chief Legal Officer at Hims & Hers Health, Inc.. 8,023 shares at an average of $57.75, traded Jun 16, 2025, filed Jun 17, 2025.

Warning score
12
Value
$463k
8,023 shares
Holdings after
163,309
-5% from before
From 52-week low
+291%
low $15.27, close $59.78
From 52-week high
-13%
high $68.74, as of Jun 16, 2025

Score components

  • Role
    Officer
    +15
  • Trade size
    $463k at market
    +17
  • Share of holdings sold
    Sold 4.7% of holdings
    0
  • Cluster
    5 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -15.6%, 3m -14.1%, 6m -37.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

HIMSOct 9, 2026 · close 30.92
Since filing Jun 17, 2025: -47.8%SPY +32.4% · excess -80.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001773751-25-000220, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 13, 2025MOption exercise
Class A Common Stock10b5-1
+41,420--194,614Jun 17, 2025
Jun 13, 2025FTax withholding
Class A Common Stock10b5-1
-23,282$55.48$1.3M171,332Jun 17, 2025
Jun 16, 2025SOpen-market sale
Class A Common Stock10b5-1
-5,451$56.80$310k165,881Jun 17, 2025
Jun 17, 2025SOpen-market sale
Class A Common Stock10b5-1
-2,572$59.75$154k163,309Jun 17, 2025
Jun 13, 2025MOption exercise
Restricted Stock Unitderivative10b5-1
-10,916$0.00$032,747Jun 17, 2025
Jun 13, 2025MOption exercise
Restricted Stock Unitderivative10b5-1
-12,223$0.00$085,561Jun 17, 2025
Jun 13, 2025MOption exercise
Restricted Stock Unitderivative10b5-1
-12,099$0.00$0133,089Jun 17, 2025
Jun 13, 2025MOption exercise
Restricted Stock Unitderivative10b5-1
-6,182$0.00$092,743Jun 17, 2025

Related signals

Other insiders at Hims & Hers Health, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
13Weak
HIMSsell 210b5-1
Hims & Hers Health, Inc.
Soleil Boughton
Chief Legal Officer
$101k
3,461 shares
-1%
17Weak
HIMSsell 210b5-1
Hims & Hers Health, Inc.
Oluyemi Okupe
Chief Financial Officer
$59k
2,000 shares
-1%
30Weak
HIMSsell 410b5-1
Hims & Hers Health, Inc.
Oluyemi Okupe
Chief Financial Officer
$877k
29,277 shares
-11%
32Weak
HIMSsell 410b5-1
Hims & Hers Health, Inc.
Oluyemi Okupe
Chief Financial Officer
$355k
12,313 shares
-5%
21Weak
HIMSsell 410b5-1
Hims & Hers Health, Inc.
Soleil Boughton
Chief Legal Officer
$174k
6,236 shares
-2%
31Weak
HIMSsell 410b5-1
Hims & Hers Health, Inc.
Michael Chi
Chief Operating Officer
$398k
14,027 shares
-3%
23Weak
HIMSsell 410b5-1
Hims & Hers Health, Inc.
Mohamed Elshenawy
CTO
$226k
7,954 shares
-4%
20Weak
HIMSsell 410b5-1
Hims & Hers Health, Inc.
Soleil Boughton
Chief Legal Officer
$98k
3,458 shares
-1%
37Weak
HIMSsell 310b5-1
Hims & Hers Health, Inc.
Deborah M. Autor
Chief Policy Officer
$467k
16,773 shares
-26%
31Weak
HIMSsell 310b5-1
Hims & Hers Health, Inc.
Soleil Boughton
Chief Legal Officer
$692k
25,111 shares
-7%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Soleil Boughton sold $463k of HIMS | InsiderTell